U.S. Entertainment Stock News

NYSE:MCO
NYSE:MCOCapital Markets

Moody's (MCO) Posted Strong Q2 Growth, Is The Stock Fully Priced?

Moody's (MCO) stock is in focus after the company reported second quarter results that showed higher revenue, net income and earnings per share compared with the same period a year earlier. See our latest analysis for Moody's. Moody's stock has eased slightly in the wake of the earnings release, with a 7.6% 1 month share price return and a decline in 1 year total shareholder return of 4.4%, which points to solid longer term momentum but some recent cooling. If Moody's results have you...
NasdaqCM:ESQ
NasdaqCM:ESQBanks

Is Esquire Financial Holdings (ESQ) Fully Valued Following Stronger Earnings?

Esquire Financial Holdings (ESQ) drew investor attention on 23 July 2026 after reporting second quarter and first half results that showed higher net interest income and net income versus the same periods last year. See our latest analysis for Esquire Financial Holdings. The earnings release sits alongside strong recent market interest in Esquire Financial Holdings, with a 21.37% 90 day share price return and a 451.32% 5 year total shareholder return that signal sustained positive momentum...
NasdaqGS:VLY
NasdaqGS:VLYBanks

Did Stronger Q2 Results and Steady Dividend Just Reframe Valley National Bancorp’s (VLY) Capital Story?

In July 2026, Valley National Bancorp reported past second-quarter 2026 results showing net interest income of US$487.02 million and net income of US$170.89 million, both higher than a year earlier, alongside lower net charge-offs of US$22.05 million versus US$37.83 million. Despite authorizing buybacks earlier in the year, the bank repurchased no shares in the most recent quarter while still affirming a quarterly dividend of US$0.11 per share, underscoring a preference for cash returns over...
NYSE:RITM
NYSE:RITMMortgage REITs

Rithm Capital (RITM) Stock Rises As Dividend Cover Outruns Thin Profit

Rithm Capital stock was edging higher in regular trading on Tuesday, up a little over 1% around US$9.90, even as the headline earnings print looked soft. Net income came in at US$20.2 million for the quarter and basic earnings per share landed near US$0.04, a much thinner result than recent quarters. The market’s first take is mild relief rather than excitement. For long term investors, the focus now shifts to whether this mortgage and real estate platform can protect margins and support its...
NYSE:INFQ
NYSE:INFQTech

Infleqtion (INFQ) Stock Still Looks Fully Priced After A 44% Fall

Infleqtion stock has fallen sharply year to date, yet the broader valuation checks currently lean toward the shares looking expensive rather than like a clear bargain. Infleqtion is down 44.2% year to date, which raises the question of whether the recent share price slide has fully reset expectations or if investors are still paying up for the story. Fresh government projects, new deployments and leadership hires can support long term demand for Infleqtion's quantum systems, but execution...
NasdaqGS:FIZZ
NasdaqGS:FIZZBeverage

National Beverage (FIZZ) Could Be 17% Below Fair Value Following Its Recent Bounce

Recent price action and context for National Beverage National Beverage (FIZZ) recently attracted investor attention after a 4.1% gain in a single session, with the stock closing at $32.54 on 28 July 2026. That move follows a mixed pattern, including a roughly 5.7% rise over the past week, a small decline over the past month, and a larger fall over the past 3 months and past year. See our latest analysis for National Beverage. For context, National Beverage now trades at $32.54 per share,...
NYSE:RHP
NYSE:RHPHotel and Resort REITs

The Bull Case For Ryman Hospitality Properties (RHP) Could Change Following Fresh 52-Week High On Earnings Momentum

Recently, Ryman Hospitality Properties reached a new 52-week high as investors reacted to its consistent record of topping earnings expectations and improving analyst estimates. This combination of sustained earnings outperformance and increasingly favorable analyst views is drawing attention to how Ryman’s fundamentals align with its current valuation signals. We’ll now examine how this strengthening analyst sentiment and earnings record interacts with Ryman’s existing investment narrative...
NYSE:CDP
NYSE:CDPOffice REITs

COPT Defense Properties (CDP) Stock Sees Muted Reaction To Record FFO

COPT Defense Properties stock barely moved on the earnings news, edging up about 0.5% in midday trading, yet the report itself was anything but quiet. The headline was a fresh quarterly high for funds from operations per share, a key real estate investment trust profit gauge, at US$0.71 and ahead of guidance. That came alongside a raised full year FFO outlook. The market reaction so far looks muted compared with the steady profitability trend that management is leaning on as it tweaks...
NYSE:NUE
NYSE:NUEMetals and Mining

Nucor (NUE) Stock Drops As Record Shipments Meet Valuation Doubts

Nucor stock came into this week on a strong run, then promptly slipped about 3% today as investors reacted to fresh numbers. That drop sits awkwardly against a quarter in which earnings power looked anything but soft. Basic earnings per share in Q2 landed just above US$5 on revenue of about US$10.4b, and management reported roughly US$2.0b of consolidated earnings before interest, taxes, depreciation and amortization. The real story is profit strength. Net income reached roughly US$1.2b and...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Is Safety Insurance Group (SAFT) Overvalued Following MAPFRE's $105 A Share Bid?

MAPFRE U.S.A. Corp. has agreed to acquire Safety Insurance Group (NasdaqGS:SAFT) in an all cash deal valuing the Boston based insurer at US$1.6b. The offer provides shareholders US$105 per share, which is a 44% premium to the pre announcement price. See our latest analysis for Safety Insurance Group. The MAPFRE announcement has clearly reset expectations around Safety Insurance Group, with a 7 day share price return of 40.31% and a 1 year total shareholder return of 53.56% pointing to strong...
NYSE:VMI
NYSE:VMIConstruction

Should Valmont’s Upgraded Outlook, Buybacks and Leadership Change Require Action From Valmont Industries (VMI) Investors?

In July 2026, Valmont Industries reported stronger second-quarter results, raised its full-year 2026 revenue and earnings guidance, affirmed a quarterly dividend of US$0.77 per share, completed a US$249.58 million share repurchase program covering 612,946 shares, and announced that long-time Chairman Mogens C. Bay will retire at the end of the 2026 fiscal year, to be succeeded by Catherine J. Paglia. This combination of improved outlook, capital returns through dividends and buybacks, and an...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Capricor Therapeutics (CAPR) Falls On FDA Doubts, Where Does Fair Value Sit?

Capricor Therapeutics (CAPR) is under intense scrutiny after FDA briefing documents questioned the efficacy and statistical analysis of Deramiocel for Duchenne muscular dystrophy, triggering a sharp share price drop and multiple law firm investigations. See our latest analysis for Capricor Therapeutics. The latest FDA briefing has sharply changed sentiment around Capricor Therapeutics, with the share price falling 66.8% over the past week and 76.8% year to date. At the same time, the 3 year...
NasdaqGS:GABC
NasdaqGS:GABCBanks

German American Bancorp (GABC) Stock Holds Firm As Margin Strength Meets Premium Valuation

German American Bancorp stock barely budged today, edging around 0.6% higher. This suggests the market sees this quarter as business as usual. The earnings report, however, tells a sharper story. Net interest margin, the lifeblood for a regional bank, was 4.3% in Q2, while the cost-to-income ratio improved to 47.38%. Together, these figures indicate a profitability engine that is still running efficiently, even as investors react cautiously. The key question is whether this margin strength...
NasdaqCM:SNDL
NasdaqCM:SNDLPharmaceuticals

SNDL (NasdaqCM:SNDL) Stock Struggles To Shake Losses Despite C$235.8m Revenue

SNDL slipped about 2% in midday trading, which hardly looks like panic when you set it against what just came out of the quarter. The headline is simple. Revenue held at a substantial C$235.8m while the company stayed in the red, with a net loss of C$7.8m and free cash flow still negative. For a stock that has already fallen over the past month, today’s muted move suggests investors are wrestling less with surprise and more with fatigue. The key question now is whether this latest loss...
NYSE:RSI
NYSE:RSIHospitality

Rush Street Interactive (RSI) Heads Into Earnings With Valuation Still In Focus

Rush Street Interactive (RSI) is back in focus as it prepares to report earnings after the bell this Wednesday, with the market watching an expected 36.6% year-on-year revenue increase for the quarter. See our latest analysis for Rush Street Interactive. Rush Street Interactive’s recent pullback, including a 1-day share price decline of 2.94% and 7-day share price decline of 8.8% to US$30.69, sits against a much stronger backdrop, with a 90-day share price return of 9.69%, year to date share...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Palo Alto Networks Stock Stands Out Among Earnings Momentum Picks

With major US indexes recently lifted by upbeat earnings from companies like Boeing, Ford, PayPal, and Coca-Cola, and chip stocks under pressure from fresh questions around AI funding deals and Chinese competition, stock selection matters more than ever. This Earnings Momentum Stocks screener focuses on larger companies that currently show moderate risk profiles and positive signals on both recent value gains and analyst outlooks. In this article you will see three stocks that appear...
NYSE:BDC
NYSE:BDCElectronic

Belden (BDC) Stock May Still Look Like A Bargain On Earnings

Belden stock has delivered a strong 116.0% return over the past five years, yet recent weakness and a mixed valuation score raise questions about how much upside is left at around US$104.93. Over five years Belden has returned 116.0%, which puts the recent share price pullback into context as part of a much longer positive run. Future revenue and cash flow expectations can support the current valuation, while any pressure on profitability or larger investment needs may weigh on what...
NYSE:RNST
NYSE:RNSTBanks

Renasant (RNST) Could Be 4% Undervalued Following Strong Second Quarter Results

Renasant (RNST) is in focus after reporting second quarter 2026 results, with higher net interest income and net income compared with a year ago, alongside lower net loan charge offs. See our latest analysis for Renasant. Renasant’s second quarter update comes after a strong share price run, with a 24.09% year to date share price return and a 55.62% total shareholder return over three years, which suggests momentum has been building into these results. If this kind of progress has your...
NYSE:RIG
NYSE:RIGEnergy Services

Oil Prices Surge With Iran Tensions and Put These 3 Energy Stocks in Focus

Oil and gas stocks are back in the spotlight as conflict between the U.S. and Iran disrupts supply routes and lifts fuel costs. With the Strait of Hormuz closed and consumers facing higher prices at the pump and the supermarket, energy producers sit at the center of this shock. Some companies could benefit from higher selling prices, while others face higher costs, policy risk, or demand pressure. This article walks through 3 large, financially stable oil and gas stocks that are closely...
NYSE:STNG
NYSE:STNGOil and Gas

Scorpio Tankers (STNG) Stock Could Trade At A Discount On Earnings But A Premium To Fair Value

After a very strong 5 year run, with Scorpio Tankers up about 450%, the stock now sits in a zone where its market price and intrinsic value estimate look broadly aligned rather than clearly cheap or expensive. The 5 year total return of roughly 450% puts Scorpio Tankers among the stronger performers in the sector, which naturally raises the bar for what counts as good value today. The recent move to replace higher coupon unsecured notes with a lower cost, asset backed credit facility can...
NasdaqGS:HAPN
NasdaqGS:HAPNConsumer Finance

Happen (HAPN) Stock Eyes Repricing After EPS Surge And Guidance Lift

Happen stock edged up 1.1% to US$18.95 into the close, a modest move for a quarter that put earnings power firmly in the spotlight. Traders saw a routine beat. Long term investors saw something different. Diluted EPS hit about US$0.50 for Q2, with return on tangible common equity near 15.9%, and management raised full year EPS guidance to a higher range. The near term chart still shows a decline over the past month, which keeps shorter term holders cautious. The key question now is whether...
NYSE:PII
NYSE:PIILeisure

Polaris (PII) Stock Rebound Meets Tariff Questions Despite Raised Outlook

Polaris stock came into this earnings print after a soft stretch, with the shares down over the past month and giving up another 4.2% today to close at US$71.59. That move suggests investors saw a problem. The headline numbers tell a different story. Q2 2026 flipped back to profit with basic earnings per share of US$1.85 on revenue of US$2,039.6m, after a loss in Q1. Management also raised full year guidance, which puts the focus squarely on whether this profit rebuild is durable or just a...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott (MAR) Stock Could Be 18% Overvalued On Resort Expansion News

Marriott International stock has delivered a strong 5 year run, yet current valuation checks suggest the shares are trading at a premium to an intrinsic value estimate and to market based multiples. Marriott International has returned 179.9% over the past 5 years, which puts extra attention on whether the current share price still reflects a reasonable pay off for that performance. Recent expansion moves into all inclusive resorts and branded apartments may support long term cash flow...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott (ABT) Lands Exclusive Rights To FDA Approved SimpleScreen In The U.S.

FDA has approved Freenome's SimpleScreen blood-based colorectal cancer test for average-risk adults. Abbott Laboratories, NYSE:ABT, holds exclusive rights to commercialize SimpleScreen in the U.S. This agreement expands Abbott's colorectal cancer screening portfolio and strengthens its role in blood-based diagnostics. Abbott Laboratories, NYSE:ABT, is moving into a higher profile position in colorectal cancer screening through this new U.S. commercialization partnership for SimpleScreen...